Omega Diagnostics Group PLC Director/PDMR Shareholding (0416X)
16 Dicembre 2019 - 5:05PM
UK Regulatory
TIDMODX
RNS Number : 0416X
Omega Diagnostics Group PLC
16 December 2019
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Director / PDMR Shareholding
Omega Diagnostics (AIM: ODX), the medical diagnostics company
focused on allergy, food intolerance and infectious disease,
announces that Kieron Harbinson, Group Finance Director, has sold
and bought back 4,554 Ordinary Shares in the Company. Mr
Harbinson's ownership of shares in the Company therefore remains
unchanged.
The sale of 4,554 Ordinary Shares was conducted at 11.2 pence
per share on 11 December 2019 by Mr Harbinson's pension
administrator, without his knowledge or consent. Mr Harbinson was
notified of the sale on 13 December 2019 and immediately
re-purchased the Ordinary Shares into his ISA, at a price of 13.49
pence per Ordinary Share.
Mr Harbinson's ownership of Ordinary Shares in the Company
remains unchanged at 681,617 Ordinary Shares, representing 0.45 per
cent. of the issued share capital of the Company.
The FCA notification, made in accordance with the requirements
of the EU Market Abuse Regulation is appended below.
The information communicated in this announcement is inside
information for the purposes of Article 7 of EU Regulation
596/2014.
Contacts:
Omega Diagnostics Group PLC Tel: 01259 763 030
David Evans, Non-Executive Chairman www.omegadiagnostics.com
Colin King, Chief Executive
Kieron Harbinson, Group Finance Mob: 07740 084452
Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Hannah Boros (Corporate
Finance)
Camille Gochez (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Keiron Harbinson
----------------------------------------- ------------------------------------------------------------
Reason for the notification
-------------------------------------------------------------------------------------------------------
a) Position/status: Group Finance Director
----------------------------------------- ------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
----------------------------------------- ------------------------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------------------------------
a) Name: Omega Diagnostics Group Plc
----------------------------------------- ------------------------------------------------------------
b) LEI: 2138007U9P4BTZTYIR92
----------------------------------------- ------------------------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
-------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, Ordinary Shares of 0.5 pence each
type of instrument: GB00B1VCP282
Identification code:
----------------------------------------- ------------------------------------------------------------
b) Nature of the transaction: Sale of Ordinary Shares
----------------------------------------- ------------------------------------------------------------
c) Price(s) and volume(s): Price(s) Volume(s)
11.2 pence 4,554
----------
----------------------------------------- ------------------------------------------------------------
d) Aggregated information: Single transaction as in 4 c) above Price(s) Volume(s)
* Aggregated volume: 11.2 pence 4,554
----------
* Price:
----------------------------------------- ------------------------------------------------------------
e) Date of the transaction: 11 December 2019
----------------------------------------- ------------------------------------------------------------
f) Place of the transaction: LSE
----------------------------------------- ------------------------------------------------------------
Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Keiron Harbinson
----------------------------------------- ----------------------------------------------------------
Reason for the notification
-----------------------------------------------------------------------------------------------------
a) Position/status: Group Finance Director
----------------------------------------- ----------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
----------------------------------------- ----------------------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------------------------
a) Name: Omega Diagnostics Group Plc
----------------------------------------- ----------------------------------------------------------
b) LEI: 2138007U9P4BTZTYIR92
----------------------------------------- ----------------------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
-----------------------------------------------------------------------------------------------------
a) Description of the financial instrument, Ordinary Shares of 0.5 pence each
type of instrument: GB00B1VCP282
Identification code:
----------------------------------------- ----------------------------------------------------------
b) Nature of the transaction: Purchase of Ordinary Shares
----------------------------------------- ----------------------------------------------------------
c) Price(s) and volume(s): Price(s) Volume(s)
13.49 pence 4,554
----------
----------------------------------------- ----------------------------------------------------------
d) Aggregated information: Single transaction as in 4 c) above Price(s) Volume(s)
* Aggregated volume: 13.49
pence 4,554
----------
* Price:
----------------------------------------- ----------------------------------------------------------
e) Date of the transaction: 16 December 2019
----------------------------------------- ----------------------------------------------------------
f) Place of the transaction: LSE
----------------------------------------- ----------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBUBDDCUBBGCL
(END) Dow Jones Newswires
December 16, 2019 11:05 ET (16:05 GMT)
Grafico Azioni Omega Diagnostics (LSE:ODX)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Omega Diagnostics (LSE:ODX)
Storico
Da Apr 2023 a Apr 2024
